Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
Ask the RN Question: My next visit with the oncologist is on 10/13 (every three months) and I’m extremely concerned about Immunoglobulin issues. Regarding immunity issues, my IgA (17 mg/dl) and IgG (383 mg/dl) are significantly below the normal ranges, and both
Ask the Doctor Question: I am a CLL patient (age 77) anticipating international travel. After d/c ibrutinib treatment, three vaccine doses, but no antibody after vaccine. Monoclonals are not available in absence of symptoms or positive test. Would IVIG be
Ask the Doctor Question: My husband has just started SCIG for secondary immune deficiency. How soon would any of the globulin he is receiving start to offer some protection against COVID? (We are in Canada.) Answer: SCIG in Canada is similar
Ask the Doctor Question: I am a R/R CLL patient currently on my fifth line of treatment with venetoclax and obinutuzumab and participate in the LLS COVID antibody research study. I received my second dose of the Pfizer vaccine in
Ask the Doctor Question: I take an IVIG infusion every four weeks. Now research indicates that gamunex contains some of the virus from plasma from previously infected patients. It indicates that the percentage of virus in the IVIG will increase.
Immunotherapy is most broadly defined as any treatment that uses a person’s own immune system to fight cancer by boosting or changing how the immune system works so it can better find and attack cancer cells.
One click to our most popular content.
